Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective Study from a Single Center in Kosovo

Edmond Komoni; Fisnik Jashari; Dren Boshnjaku; Blerim Myftiu; Melihate Pushka; Afrim Blyta; Rajmonda Nallbani-Komoni

doi:10.12659/MSM.942992

30 January 2024 : Clinical Research

Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective Study from a Single Center in Kosovo

Edmond Komoni^1ABCDEFG, Fisnik Jashari^1ACD, Dren Boshnjaku^1DF, Blerim Myftiu^2BF, Melihate Pushka^1BF, Afrim Blyta^1A, Rajmonda Nallbani-Komoni

^3ACEF*

DOI: 10.12659/MSM.942992

Med Sci Monit 2024; 30:e942992

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Severity of COVID-19 symptoms in patients with MS. (A) Patients categorized based on the type of MS; (B) Patients categorized based on DMTs. DMT – disease-modifying therapy; MS – multiple sclerosis. RRMS – relapsing-remitting MS; SPMS – second primary MS; PPMS – primary progressive MS.

Back to the Article

Risk Factors and Clinical Outcomes of COVID-19 Infection in Multiple Sclerosis Patients: A Retrospective Study from a Single Center in Kosovo

Your Privacy